Scenarios that move CRSP
CRISPR Therapeutics AG - Common Shares
Scenarios that move CRSP: 6 analyses, 2 positive, 4 negative.
- · SRX Global SPV agrees to acquire CERo Therapeutics — ▲ · impact +40 · confidence low · horizon weeks
- · Spyre Therapeutics prices $350 million public stock offering — ▼ · impact -20 · confidence low · horizon weeks
- · uniQure plunges after additional Huntington's disease study data — ▼ · impact -40 · confidence low · horizon immediate
- · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▼ · impact -30 · confidence low · horizon quarters
- · Sion cuts workforce nearly half after CF study failure — ▲ · impact +40 · confidence low · horizon weeks
- · Ascendis announces planned $400 million share repurchase program — ▼ · impact -20 · confidence low · horizon weeks